Dr. Yaroslav Winter

Philipps University, Germany

Senior Research Fellow

Email: yaroslav.winter@med.uni-marburg.de

Qualifications

2008 Ph.D., Psychiatrist and Research Fellow, Center for Mental Health, Klinikum Stuttgart, University Tuebingen, Germany

2006 M.Sc.,  Neurologist and Research Fellow, Dept. of Neurology, KlinikumMannheim, Ruprecht-Karls-University Heidelberg, German

2003 B.Sc.,  Medical School, University of Moscow, Russia and Philipps University Marburg, Germany

Publications (selected)

1. Winter Y, Stamelou M, Cabanel N, Sixel-Döring F, Eggert K, Höglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE. Cost-of-illness in multiple system atrophy and progressive supranuclear palsy. J Neurol. 2011 Oct; 258 (10): 1827-34.
2. Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Höglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R. Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy. Neurodegener Dis. 2011 8 (6): 438-46.
3. Winter Y, Back T, Scherag A, Linseisen J, Rohrmann S, Lanczik O, Hinney A, Scherag S, Neumaier M, Ringleb PA, Dodel R, Hebebrand J. Evaluation of the Obesity Genes FTO and MC4R and the Type 2 Diabetes Mellitus Gene TCF7L2 for Contribution to Stroke Risk: The Mannheim-Heidelberg Stroke Study. Obes Facts. 2011; 4 (4): 290-6.
4. Winter Y, Oertel WH, Dodel R. Is there underfunding in brain research? The UK research expenditure. Eur J Neurol. Eur J Neurol. 2012 Jan; 19 (1): 4-5.
5. The economic cost of brain disorders in Europe. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B; CDBE2010 study group; European Brain Council. Eur J Neurol. 2012 Jan; 19(1): 155-62.
6. Winter Y, Dodel R, Korchounov A, Grond M, Oertel WH, Back T. Clinical and pharmacological properties of new oral anticoagulants for the prevention of cerebral thromboembolism: Factor Xa and thrombin inhibitors. World J of Neuroscience 2012, 2 (1): 1-6.
7. Reese JP, Balzer-Geldsetzer M, Dams J, Winter Y, Oertel WH, Dodel R. Pharmacoeconomic Considerations of Treating Patients with Advanced Parkinson’s Disease. Expert Opin Pharmacother 2012, Mar 6 [accepted].
8. Korchounov A*, Winter Y*, Meyer MF, Rössy W. Combined beneficial effect of rasagiline on motor function and depression in de novo PD: preliminary study. Clinical Neuropharmacology 2011, Oct 21[accepted]. (* equal contribution).
9. Winter Y, von Campenhausen S, Arend M, Longo K, Boetzel K, Eggert K, Oertel WH, Dodel R, Barone P. Health-related quality of life and its determinants in Parkinson's disease: Results of an Italian cohort study. Parkinsonism Relat Disord. 2011 May; 17 (4): 265-9.
10. Winter Y, Korchounov A, Zhukova TV, Bertschi NE. Depression in elderly patients with Alzheimer dementia or vascular dementia and its influence on their quality of life. J Neurosci Rural Pract 2011; 2: 27-32.
11. Klotsche J, Reese JP, Winter Y, Oertel WH, Irving H, Wittchen HU, Rehm J, Dodel R. Trajectory classes of decline in health-related quality of life in Parkinson's disease: a pilot study. Value Health. 2011 Mar-Apr; 14 (2): 329-38.
12. Dolga AM, Culmsee C, de Lau L, Winter Y, Oertel WH, Luiten PG, Eisel UL. Statins--increasing or reducing the risk of Parkinson's disease? Exp Neurol. 2011 Mar; 228 (1): 1-4.
13. Reese JP, Winter Y, Rosa MM, Rodrigues E Silva AM, von Campenhausen S, Freire R, Mateus C, Balzer-Geldsetzer M, Botzel K, Oertel WH, Dodel R, Sampaio C. [Health-economic burden of Parkinson's disease in Portugal: a cohort study]. Rev Neurol. 2011 Mar 1; 52 (5): 264-74. Spanish.
14. Von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Bötzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP. Costs of illness and care in Parkinson's disease: an evaluation in six countries. Eur Neuropsychopharmacol. 2011 Feb; 21 (2): 180-91.
15. Reese JP, Winter Y, Balzer-Geldsetzer M, Bötzel K, Eggert K, Oertel WH, Dodel R, Campenhausen S. [Parkinson's disease: cost-of-illness in an outpatient cohort]. Gesundheitswesen. 2011 Jan;73 (1): 22-9.
16. Winter Y, Balzer-Geldsetzer M, von Campenhausen S, Spottke A, Eggert K, Oertel WH, Dodel R. Trends in resource utilization for Parkinson's disease in Germany. J Neurol Sci 2010; 294: 18-22.
17. Winter Y, von Campenhausen S, Gasser J, Seppi K, Reese JP, Pfeiffer KP, Botzel K, Oertel WH, Dodel R, Poewe W. Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study. J Neurol 2010; 257: 638-645.
18. Winter Y, Balzer-Geldsetzer M, Spottke A, Reese JP, Baum E, Klotsche J, Rieke J, Simonow A, Eggert K, Oertel WH, Dodel R. Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany. Eur J Neurol 2010. Mar 22 [Epub ahead of print].
19. Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Botzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E. Costs of Parkinson's disease in Eastern Europe: A Czech cohort study. Parkinsonism Relat Disord 2010; 16: 51-56.
20. Winter Y, Schepelmann K, Spottke AE, Claus D, Grothe C, Schroder R, Heuss D, Vielhaber S, Tackenberg B, Mylius V, Reese JP, Kiefer R, Schrank B, Oertel WH, Dodel R. Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 2010. Apr 10. J Neurol. 2010 Sep; 257 (9): 1473-81.
21. Winter Y, Bezdolnyy Y, Katunina E, Avakjan G, Reese JP, Klotsche J, Oertel WH, Dodel R, Gusev E. Incidence of Parkinson's disease and atypical Parkinsonism: Russian population-based study. Mov Disord 2010; 25: 349-356.
22. Schepelmann K, Winter Y, Spottke AE, Claus D, Grothe C, Schroder R, Heuss D, Vielhaber S, Mylius V, Kiefer R, Schrank B, Oertel WH, Dodel R. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 2010; 257: 15-23.
23. Winter Y, von Campenhausen S, Reese JP, Balzer-Geldsetzer M, Longo K, Spiga G, Boetzel K, Eggert K, Oertel WH, Dodel R, Barone P. Costs of Parkinson's Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study. Neurodegener Dis 2010. 2010; 7 (6): 365-72.

Profile Details

NULL